Maynard Um
-
-
-
-
-
-
-
Sutro Biopharma (STRO) PT Raised to $35 at Citizens Ahead of AACR Conference
-
-
-
-
-
-
-
Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026
-
-
-
-
-
-
-
Piper Sandler Upgrades Sutro Biopharma (STRO) to Overweight
-
-
-
-
-
-
-
BofA Securities Double Downgrades Sutro Biopharma (STRO) to Underperform
-
-
-
-
-
-
-
BofA Securities Reiterates Buy Rating on Sutro Biopharma (STRO)
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)
401,065 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

